Artelo Biosciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $671.97 Thousand, with shareholders equity totaling $5.00 million.
The company employs approximately 5 people and operates in the Health sector, within the Pharmaceutical Products industry.
Over the past 12 months, Artelo Biosciences Inc. reported $- in revenue, generating net income of $-12.67 million.
Key financial metrics include a P/E ratio of -0.05, a price-to-book (P/B) ratio of 0.13, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker ARTL.